NCT01607788

Brief Summary

The investigators propose a prospective, web-based database (developed within the framework of Quickbase, Intuit) which will allow an evaluation of the data for patients with a liver tumour who receive a liver transplant. Each site will continue to transplant according to their own criteria for inclusion on the waiting list. Each center will be responsible to enter a short list of data points at time of listing, transplant, and at 1 and 2 years post transplant. Data will be gathered prospectively through a web-based anaonymized database, and outcomes analyzed yearly X5 for tumour recurrence and patient survival.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2009

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

May 24, 2012

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 30, 2012

Completed
5.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

May 30, 2012

Status Verified

May 1, 2012

First QC Date

May 24, 2012

Last Update Submit

May 29, 2012

Conditions

Hepatocellular CarcinomaEvidence of Liver Transplantation

Keywords

Selection criteriaLiver transplantationHepatocellular carcinoma

Outcome Measures

Primary Outcomes (1)

  • Post-transplant survival

    24 months post-transplant

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients with hepatocellular carcinoma listed for liver transplantation at the participating centers

You may qualify if:

  • patients with hepatocellular carcinoma listed for liver transplantation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta

Edmonton, Canada

RECRUITING

MeSH Terms

Conditions

Carcinoma, Hepatocellular

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsLiver NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesLiver Diseases

Study Officials

  • Norman Kneteman, MD, PhD

    University of Geneva

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Norman Kneteman, MD

CONTACT

kneteman@ualberta.ca

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Médecin Adjoint Agrégé, University of Geneva

Study Record Dates

First Submitted

May 24, 2012

First Posted

May 30, 2012

Study Start

November 1, 2009

Study Completion

December 1, 2017

Last Updated

May 30, 2012

Record last verified: 2012-05

Locations

CA(1)